Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP
US Market
Holding TTNP?
Track your performance easily

Titan Pharmaceuticals (TTNP) Financial Statements

792 Followers

Titan Pharmaceuticals Financial Overview

Titan Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-6.503; its P/E ratio is -0.87; Titan Pharmaceuticals is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue--$ 4.00K$ 83.00K$ 98.00K
Gross Profit--$ 4.00K$ 83.00K-
EBIT$ -2.09M$ 1.07M$ -338.00K$ -1.59M$ 1.89M
EBITDA$ -2.09M$ 1.07M$ -311.00K$ -1.55M$ 1.94M
Net Income Common Stockholders$ -2.09M$ -1.06M$ -338.00K$ -1.59M$ 1.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.09M$ 6.16M$ 8.10M$ 105.00K$ 1.14M
Total Assets$ 4.35M$ 6.65M$ 10.00M$ 812.00K$ 2.17M
Total Debt$ 0.00$ 33.00K$ 97.00K$ 128.00K$ 158.00K
Net Debt$ -4.09M$ -6.13M$ -8.00M$ 23.00K$ -978.00K
Total Liabilities$ 356.00K$ 559.00K$ 1.87M$ 1.85M$ 2.48M
Stockholders Equity$ 3.99M$ 6.09M$ 8.13M$ -1.03M$ -312.00K
Cash Flow-
Free Cash Flow$ -2.07M$ -613.00K$ -1.61M$ -1.11M$ -1.90M
Operating Cash Flow$ -2.07M$ -613.00K$ -1.83M$ -1.11M$ -1.90M
Investing Cash Flow--$ 228.00K--
Financing Cash Flow--$ 9.59M--
Currency in USD

Titan Pharmaceuticals Earnings and Revenue History

Titan Pharmaceuticals Debt to Assets

Titan Pharmaceuticals Cash Flow

Titan Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis